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ABSTRACT
Lehman, J. S., and Oudemans, P. V. 1997. Phenology of apothecium pro-
duction in populations of Monilinia vaccinii-corymbosi from early- and
late-maturing blueberry cultivars. Phytopathology 87:218-223.
Pseudosclerotia were evaluated for differences in timing of apothe-
cium development in four controlled experiments conducted over a 2-year
period. In a separate experiment, conidia from 10 randomly selected iso-
lates from both of the fungal populations were used to inoculate open
flowers. Germination of pseudosclerotia produced from these artificial
inoculations also was evaluated. The timing and rate of shoot elongation
for cvs. Weymouth and Jersey were assessed in one greenhouse and two
field experiments. Average development times for the fungal population
from cv. Weymouth were 8 to 15 days earlier or 33 to 42% less than
those for the population from cv. Jersey. The fungal population from
Weymouth also exhibited less variation in development times for each
developmental stage measured. Similarly, germination of pseudosclerotia
produced in artificial inoculations differed between populations. On av-
erage, pseudosclerotia derived from the Weymouth population produced
apothecia 16 days earlier. During spring 1995 and 1996, vegetative and
truss buds on cv. Weymouth developed 4 to 16 days earlier than those on
cv. Jersey. These results demonstrate that M. vaccinii-corymbosi exhibits
variation in timing of pseudosclerotia germination and apothecium de-
velopment within and between populations. We hypothesize that differ-
ences observed in the timing of apothecium development are related to
the fitness of the populations on their original host cultivars and were
selected by host phenology.
Additional keywords: fungal adaptation, fungal fitness, mummy berry dis-
ease, phenological development.
Mummy berry disease, caused by Monilinia vaccinii-corymbosi
(Reade) Honey, occurs in commercial and native stands of Vac-
cinium spp. throughout North America and northern Europe (8,
12). The disease reduces yield by blighting newly formed vegeta-
tive and flower truss buds (primary infection) or causing hard rot
of fruit (secondary infection). These two phases of the disease
cycle are caused by ascospore and conidial infections, respectively
(24).
The disease is initiated during the spring when pseudosclerotia,
the overwintering structure of M. vaccinii-corymbosi, germinate
and produce apothecia from which ascospores are discharged. The
process of germination begins with the production of stipe initials
(i.e., small projections from the pseudosclerotium that later form
stalks on which the disks of the apothecia develop). Stipe initials
elongate and eventually form apical invaginations or dimples that
give individual stipes the appearance of a finishing nail. The api-
cal tip of the stipe expands and forms a hollow, bulblike swelling.
Eventually, the tip of the stipe forms an urnulate disk with a
distinct inrolled margin. This goblet-like structure continues to
expand and develops into mature apothecium and ascospores (3).
Wind-blown ascospores infect breaking buds and young elongat-
ing shoots of blueberry hosts (Vaccinium spp.) (21,22). Conidia
produced from these primary infections are carried to the styles,
where conidia germinate and infect the ovary (17). Infected flow-
ers become ramified with fungal tissue and form a mummified
fruit (pseudosclerotium).
Resistance to both the primary and secondary phases of the
disease has been identified (11,18,20,23,24); however, results of
germplasm surveys vary across environments (20,23). Some stud-
ies have indicated that timing of bud break, as measured by host
shoot length, and disease resistance are negatively correlated (11,
20). Thus, disease avoidance may provide a significant portion of
resistance to the mummy berry pathogen in blueberries.
Disease avoidance differs from disease escape in that avoidance
is the result of host genotype, whereas escape is a random process
(6). Because of the genetic basis of disease avoidance, pathogens
potentially can adapt to avoidance mechanisms provided pathogen
populations exhibit variation to these traits (6). In a broader con-
text, the specialization of Monilinia spp. to host species in the
subfamily Vacciniodeae may be due, in part, to the adaptation of
pathogen phenologies to coordinate with those of divergent hosts.
Batra (2) reported differences in apothecium development among
populations of M. vaccinii-corymbosi and M. gaylussacia, two
closely related fungal species with similar life cycles and related
host species. The results of Batra’s (2) work over a 3-year period
demonstrated that apothecial formation of M. vaccinii-corymbosi
was consistently 10 to 16 days earlier than M. gaylussacia (2).
This difference corresponds to the difference in the phenologies of
the two host species located at the same site.
It is unknown whether populations of M. vaccinii-corymbosi
adapt to the phenologies of highbush blueberry cultivars or how
host and pathogen phenologies influence disease. Host blueberry
cultivars with varied phenologies could impose selection pressure
for pathogen isolates with corresponding phenologies because of a
greater likelihood for infection compared to early- or late-develop-
ing isolates. Such isolates would have a reproductive advantage,
enabling them to increase in frequency and potentially change the
average phenology of the population, provided pathogen phenol-
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ogy is heritable. To determine how host and pathogen phenologies
influence disease, we have been studying the variation in timing
of apothecium development for populations of M. vaccinii-cor-
ymbosi and how it coordinates with the timing of host bud break
and shoot development. The specific objectives of our study were
to determine whether differences in phenological development ex-
ist between blueberry cultivars and between pathogen populations
and whether evidence exists for adaptation of pathogen popula-
tions to the phenology of different cultivars.
MATERIALS AND METHODS
Wild-type populations of M. vaccinii-corymbosi. Two popula-
tions of M. vaccinii-corymbosi, 9420-WT and 9421-WT, were
collected in 1994 and 1995 from naturally infected blueberry bushes
growing near Chatsworth, NJ (15). Pseudosclerotia of population
9420-WT were collected from bushes of early-fruiting cv. Wey-
mouth (10) that had been in continuous commercial production for
more than 40 years. Pseudosclerotial density at the collection site
was 5 to 15 per bush despite spring applications of the fungicide
triforine. Pseudosclerotia of population 9421-WT were collected
from late-fruiting cv. Jersey (10). Bushes at the site were also more
than 40 years old but had not been in commercial production for
~15 years. Pseudosclerotial density was one to five per bush. Pseudo-
sclerotia collected from these populations were used in a green-
house to evaluate the phenological (experiments I through III) and
morphological development (experiment IV) of M. vaccinii-cor-
ymbosi.
Conditions for apothecial production. In all greenhouse ex-
periments, pseudosclerotia from individual collection sites were
buried approximately 0.5 cm below the surface of moist soil (washed
sand/peat moss, 1:1, by volume) in 17 × 38-cm flats. Wire screen
was positioned over the pseudosclerotia, and moist sphagnum moss
was placed over the screen. Flats were watered and maintained in
a greenhouse at 20 to 27°C with natural lighting for 1 month and
then moved outside at ambient temperatures to fulfill the chilling
requirement of the pseudosclerotia (5,16). The sphagnum moss
and screen were removed from the flats on 19 February 1995 (ex-
periments I, II, and IV) and 19 January 1996 (experiment III) after
pseudosclerotia had received ~1,200 hours between 0 and 7°C.
Flats were immediately transferred to a greenhouse at 15°C to
initiate pseudosclerotial germination and apothecium production.
In addition to natural lighting, flats received 12 hours of supple-
mental fluorescent lighting per day.
Pseudosclerotial germination and apothecium development.
Pseudosclerotia were monitored daily throughout the germination
and apothecium development period. Mean development times for
each fungal population were determined from daily counts of the
number of newly formed stipes, invaginated stipes, expanding stipes,
or mature apothecia. Development times, expressed as days at
15°C, were calculated as the weighted mean time from the equation
mean development time
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where Pi is the proportion of newly formed stipes, invaginated
stipes, expanding stipes, or mature apothecia that appear on the i th
day at 15°C relative to the final number of individuals in these
developmental stages, ti is the i th day at 15°C, and n is the number
of days at 15°C when the maximum number of individuals from
each developmental stage have appeared. In addition, we calcu-
lated the variance of the distribution of development times for fun-
gal structures from the equation
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Development rates for pseudosclerotium germination and
apothecium production. The rate of development for each stage
of pseudosclerotial germination was calculated from the cumula-
tive values of the relative number of developmental structures
present on each day. Cumulative values (Y ) were transformed with
a Gompertz-transformation (Gompertz Y = –1n(–1n(Y )) (7), and
regression analysis was used to fit a straight-line equation. Slopes
of the equations approximate the rate at which developmental
structures were formed for a population of pseudosclerotia. The x-
intercepts from the regression equations were used to calculate
differences in the development times for each stage of germi-
nation.
Width of the uppermost portion of 10 random stipes was mea-
sured at 2- to 3-day intervals throughout apothecium development.
Rates of expansion for stipe apices were calculated from width
data that were log-transformed to linearize the relationship be-
tween width and time. Least squares regression equations were fit
to calculate the slopes and x-intercepts.
Artificial inoculations. Cultures of M. vaccinii-corymbosi were
isolated from each fungal population by surface-sterilizing pseudo-
sclerotia for 5 min in a 95% ethanol/5% sodium hypochlorite
solution (1:1, by volume) and placing pseudosclerotia on potato
dextrose agar. Pure-cultured isolates were plated on cellulose mem-
branes (Gelman Sciences, Ann Arbor, MI) on V8 agar to induce
conidium production (4). Conidia were collected by vacuuming
the colony surface with a Pasteur pipette inserted in the end of a
piece of rubber tubing (5 mm inner diameter) attached to a vac-
uum pump. Conidia were filtered out of the air flow with a 3-mm
syringe filter (Micron Separations, Inc., Westboro, MA) inserted
in the air line between the pipette and pump and then were mixed
with roughly equal amounts of pollen from blueberry cv. Blue-
crop. Flowers of cv. Jersey were inoculated in the greenhouse by
transferring dry conidia/pollen to the stigmatic surfaces of open
flowers with a fine glass rod. Infected flowers developed into
pseudosclerotia. The development of mature apothecia from pseudo-
sclerotia of both populations was assessed as described earlier for
experiment III.
Morphological measurements of fungal apothecia. In experi-
ment IV, the final dimensions of the mature, fully formed apo-
thecia were measured after a distinct margin formed on the cup’s
outer edge. Apothecia were clipped from the pseudosclerotia, and
dimensions of the apothecium were measured. Characteristics
measured included diameter and depth (inner and outer) of a fully
expanded cup, width of the stipe 3 to 5 mm below the cup portion
of the apothecium, length of the stalk supporting the apothecial
cup, and overall height of the apothecium. Morphological dimen-
sions of about 350 newly formed apothecia from each fungal
population were measured.
Host development. The phenological development of plants of
cvs. Weymouth and Jersey were measured in three field experi-
ments during the spring of 1995 and 1996 and one greenhouse
experiment during the spring of 1996. The field experiments were
conducted at three locations in Burlington County, NJ, including
the original collection site for populations 9420-WT and 9421-
WT. The plants at two of the locations were established bushes,
whereas plants at the third location were 2-year-old bushes. At
each location, shoot length was measured for elongating buds at 5-
to 7-day intervals. Lengths were log-transformed to linearize the
relationship between shoot length and time. Least squares regres-
sion equations were fit to calculate slopes and x-intercepts. The
slopes and x-intercepts were used to estimate the rate and timing
of shoot elongation, respectively, for cvs. Weymouth and Jersey.
In the greenhouse experiment, 2-year-old potted plants of cvs.
Weymouth and Jersey were moved to a greenhouse maintained at
15°C on 19 January 1996 after receiving 1,100 to 1,200 hours
between 0 and 7°C in an unheated screenhouse. Shoot length was
recorded and analyzed as previously described.
Statistical analyses. Experiments I through III were random-
ized complete block designs with two fungal populations and either
eight (experiments I and II) or five replications (experiment III).
Blocks were locations on a greenhouse bench. Each experimental
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unit was composed of 50 pseudosclerotia. Because the number of
replications within experiments was unequal, the combined anal-
yses of experiments I through III were performed on treatment
means averaged across replication within experiments (i.e., un-
weighted mean analysis) (9,19). Unweighted mean analyses were
used to compare fungal populations 9420-WT and 9421-WT for
differences in timing and rate of pseudosclerotial germination and
apothecium production. The artificial inoculation experiment was
a randomized complete block design of three replications and two
populations. Only the development time for the production of ma-
ture apothecia and its variance were compared for this experiment.
Analysis of variance was used to compare fungal populations 9420-
WT and 9421-WT for morphological differences (experiment IV).
Experiment IV employed a completely randomized design with
four replications and two fungal populations. Each experimental
unit was composed of 100 pseudosclerotia.
Unweighted mean analyses (previously described) of four ex-
periments also were used to compare shoot elongation. The indi-
vidual experiments within these analyses were completely ran-
domized designs of three to five replications and two fungal
populations. Each replication included a sample of 5 to 15 vege-
tative buds from the same plant.
RESULTS
Pseudosclerotial germination and apothecium development.
The proportion of pseudosclerotia that germinated was similar
across all experiments (0.5 to 0.6) and did not differ for fungal
populations (P = 0.54). Percent germination was similar to pre-
vious reports conducted under different environmental conditions
(5,17). Within a population of pseudosclerotia, germination was
not synchronous. Rather, the production of newly formed stipes,
invaginated stipes, expanding stipes, or mature apothecia occurred
over a period of days. In general, the daily distribution of newly
formed structures approximated a normal distribution (Fig. 1A
through D) and, therefore, could be summarized by the mean and
variance of the distribution indicative of its timing and uniformity,
respectively.
Differences in development times for fungal populations 9420-
WT and 9421-WT were significant for all stages of germination
(P < 0.001 for individual analyses of experiments; P = 0.01 to
0.03 for combined analyses of experiments). In the combined
analyses, the average development times for fungal population
9420-WT were 8 to 15 days earlier than those for population
9421-WT (Table 1). The smallest difference in development
time between fungal populations was observed in the production
of stipes.
Variances for developmental distributions ranged from 12 to 70
days. Except for the production of mature apothecia, variances for
development of population 9421-WT were significantly larger
than those for population 9420-WT (P < 0.001 for individual anal-
yses of experiments; P = 0.02-0.04 for combined analyses of ex-
periments). The greatest difference was in the production of stipes,
in which population 9420-WT exhibited almost one-half the varia-
tion exhibited by population 9421-WT.
Data from experiment I are presented graphically to demon-
strate the variation in pseudosclerotial germination within and be-
tween fungal populations (Fig. 1). Results for experiments II and
III were similar to experiment I. In experiment I, population 9421-
WT produced above-ground stipes from days 9 to 37 at 15°C (Fig.
1A). Population 9420-WT produced stipes from days 7 to 18 (Fig.
1A). The mean development times for the production of stipes
differed by 7 days and were 11 and 18 days for populations 9420-
WT and 9421-WT, respectively. Similarly, population 9420-WT pro-
duced stipes with apical invaginations and stipes with expanding
apical tips across an earlier range of days than did population
9421-WT (Fig. 1B and C). The mean development times for the
production of invaginated stipes were 16 and 27 days for popula-
tions 9420-WT and 9421-WT, respectively. Mean development
times for expanded stipes were 18 and 30 days for populations
9420-WT and 9421-WT, respectively. Differences between popu-
lations for the two developmental stages were 11 to 12 days. Pop-
ulation 9420-WT produced mature apothecia across an earlier range
of days after exposure to 15°C than did population 9421-WT (Fig.
Fig. 1. Daily formation of A, newly formed stipes; B, invaginated stipes; C,
expanding stipes; or D, mature apothecia from pseudosclerotia of Monilinia
vaccinii-corymbosi. Populations 9420-WT and 9421-WT were collected from
early- and late-maturing blueberry cvs. Weymouth and Jersey, respectively. Dis-
tributions are for the development of 400 pseudosclerotia from each popu-
lation in experiment I.
TABLE 1. Mean development times, variances, and rates for four stages of
apothecium development for Monilinia vaccinii-corymbosi populations 9420-
WT and 9421-WT y from early- and late-fruiting blueberry cvs. Weymouth
and Jersey, respectively
Developmental
stage Population
Development
time (days)
Variance
(days)
Rate
(no./day)
Newly 9420-WT z14.1 bz 26.6 b 0.50 a
  formed stipes 9421-WT 21.8 a 69.7 a 0.15 b
Invaginated 9420-WT 19.3 b 23.4 b 0.30 a
  stipes 9421-WT 33.0 a 42.1 a 0.18 b
Expanded 9420-WT 21.8 b 15.6 b 0.35 a
  stipes 9421-WT 36.7 a 30.1 a 0.21 b
Mature 9420-WT 28.2 b 11.5 a 0.35 a
  apothecia 9421-WT 41.9 a 14.9 a 0.27 b
y Values for development times, variances, and rates are the means of three ex-
periments of five or eight replications. Each replication consisted of 50
pseudosclerotia. Values for rates were calculated from Gompertz-
transformed data.
z Within developmental stages, populations with a letter in common do not
differ significantly according to the Student-Newman-Keuls’ test (α = 0.05)
for each analysis of development time, variance, or rate.
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1D). The average time required to produce a mature apothecium
was 11 days earlier for population 9420-WT. The mean develop-
ment times were 25 and 35 for populations 9420-WT and 9421-
WT, respectively.
Differences in development rates for fungal populations. The
cumulative plot of the relative number of development structures
present on each day was a sigmoid curve that was asymmetrical
around the inflection point (Fig. 2A through D). The development
for each stage of germination was more rapid for times before the
inflection point than after the inflection point. Differences in de-
velopment rates for Gompertz-transformed data were significant at
all stages of germination (P < 0.001 for individual analyses of
experiments; P = 0.01 to 0.03 for combined analyses of experi-
ments); the greatest difference was in stipe production (Table 1).
The rate for the production of stipes was 3.3 times greater for
population 9420-WT than for population 9421-WT. Values for
population 9420-WT for the other stages of development were 1.3
to 1.7 times larger.
The expansion of apical tips over time was exponential (Fig. 3).
A log-transformation of the width of apices linearized the rela-
tionship between apical width and time. Rates at which apical tips
expanded to form mature, fully formed cups differed significantly
between populations (P < 0.001 for individual analyses of experi-
ments; P = 0.001 for combined analyses). Above-ground stipes of
population 9420-WT expanded to form mature cups 37% faster
than did those of population 9421-WT. Expansion rates of log-trans-
formed values were 0.07 and 0.05 mm/day for fungal populations
9420-WT and 9421-WT, respectively. In combined analyses, x-in-
tercepts for populations 9420-WT and 9421-WT were signifi-
cantly different (P = 0.02) and represent an 11-day difference in
development times.
Artificial inoculations. Differences in timing of apothecia for-
mation from pseudosclerotia produced by artificial inoculation were
significant (P = 0.006). The average development times for apo-
thecia produced from isolates of fungal populations 9420-WT and
9421-WT were 32 and 48 days, respectively (Fig. 4). In addition,
the range of days across which apothecia derived from 9421-WT
developed was about five times greater than that for population
9420-WT.
Comparison of morphological traits. The morphology of
the apothecium differed for populations 9420-WT and 9421-WT
Fig. 2. Cumulative formation of A, newly formed stipes; B, invaginated stipes;
C, expanding stipes; or D, mature apothecia from pseudosclerotia of Moni-
linia vaccinii-corymbosi. Populations 9420-WT and 9421-WT were collected
from early- and late-maturing blueberry cvs. Weymouth and Jersey, respec-
tively. Distributions are for the development of 400 pseudosclerotia from each
population in experiment I.
Fig. 3. A, Elongation of shoots of blueberry cvs. Weymouth and Jersey, and
B, expansion of stipe apices of populations 9420-WT and 9421-WT of Moni-
linia vaccinii-corymbosi at 15°C. Shoot length for each cultivar is the aver-
age of five replications of 10 shoots. Apical widths of the pathogen are the
averages of five replications of 10 stipes.
Fig. 4. Daily formation of mature apothecia from pseudosclerotia of Moni-
linia vaccinii-corymbosi produced in artificial inoculations of cv. Jersey. Pop-
ulations 9420-WT and 9421-WT were collected from early- and late-matur-
ing blueberry cvs. Weymouth and Jersey, respectively. Distributions are for
the development of 60 pseudosclerotia from each pathogen population. The
mean and variance of the distribution for population 9420-WT were 32 and
11 days, respectively. For population 9421-WT, they were 48 and 61 days,
respectively.
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(Table 2). Differences in height of an apothecium between popula-
tions were significant (P = 0.01) as were differences between pop-
ulations for width and length of the stalk that supports the cup
portion of the apothecium (P = 0.01 and 0.004, respectively). Av-
erage height of an apothecium for population 9421-WT was 10.6 mm,
14% taller than that of population 9420-WT (Table 2). The av-
erage length of the stalk supporting the apothecium cup was 7.2 mm
and 20% longer than the length of stalks produced by population
9420-WT (Table 2). In contrast, population 9420-WT produced
apothecia with stalks that were 0.3 mm wider than those of popu-
lation 9421-WT. Morphological dimensions of the apothecium
cup (i.e., diameter of the cup and inner and outer depth of the cup)
did not differ for fungal populations (P = 0.3 to 0.8).
Vegetative and floral bud development of host cultivars. The
pattern of shoot elongation for blueberry cvs. Weymouth and Jer-
sey was similar (Fig. 3). The rates of increase in shoot length were
0.45 and 0.47 mm/day for Weymouth and Jersey, respectively, and
were not statistically different (P = 0.60 for combined analyses).
However, the x-intercept, which reflects the timing of shoot elon-
gation, indicates that the elongation of shoots of cv. Weymouth
preceded that of Jersey by ~8 days in field and greenhouse experi-
ments. Similarly, Weymouth produced fully formed, open flowers
11 days earlier than did Jersey.
DISCUSSION
This study addresses two aspects of the disease cycle of M. vac-
cinii-corymbosi: variation in timing of apothecium development
within and between populations of the pathogen and differences in
the timing of development of susceptible host tissue between two
blueberry cultivars. The underlying objectives of the study were to
determine whether differences in early development exist between
cultivars, and whether there is evidence of adaptation of pathogen
populations to the phenology of different cultivars.
Results from four experiments conducted over a 2-year period
show that 8- to 16-day differences in the initiation and rate of
apothecium development, and likely ascospore production, exist
between M. vaccinii-corymbosi populations from early- and late-
maturing blueberry cultivars. The direction and magnitude of these
differences were similar to differences in the phenologies found
for host cultivars from which the pathogen populations were col-
lected. Buds of cv. Weymouth began to break and elongate 4 to 16
days earlier than those of Jersey.
Three possible hypotheses exist to explain the differences ob-
served among pathogen populations. First, pathogen phenology
could be the result of the genotype of the infected host (i.e., phe-
notypic plasticity) (13). For example, any M. vaccinii-corymbosi
isolate that infects cv. Weymouth would produce pseudosclerotia
with an early phenology. This could be the result of pseudoscle-
rotia maturing earlier in the season and entering into a dormancy
period before those from later-maturing cultivars. Other host char-
acteristics, such as susceptibility or fruit chemistry, could poten-
tially alter the patterns of germination of pseudosclerotia, irre-
spective of fungal genotype. Phenotypic plasticity is an unlikely
explanation because differences in pseudosclerotial germination
and apothecial development of randomly selected isolates inocu-
lated in a common host background were the same as differences
seen among field-collected pseudosclerotia in different blueberry
cultivars.
A second hypothesis is that germination is regulated indirectly
through microenvironmental cues controlled by the host. For ex-
ample, carpogenic germination of sclerotia of Sclerotinia scleroti-
orum begins as the host canopy closes and creates a microclimate
optimum for germination (1). It has been demonstrated that pseudo-
sclerotial germination in M. vaccinii-corymbosi is dependent on
several environmental factors, including a chilling period, adequate
moisture, and proper temperatures (5,16,17). If the differences in
host phenology were sufficient to create distinct microclimates,
the timing of ascospore production could be regulated by host de-
velopment. This seems an unlikely scenario for M. vaccinii-cor-
ymbosi, because differences in the phenology of apothecium de-
velopment were observed in greenhouse experiments in which
microclimate variation was reduced in the experimental design.
A third hypothesis is that the differences exhibited by fungal
populations are genetically based and likely the result of adap-
tation to blueberry cultivars with different phenologies. Pseudo-
sclerotial germination in the greenhouse occurred in the absence
of the host canopy but was correlated with host phenology. Dif-
ferences in timing between pathogen populations were found in
both field-collected mummies as well as second generation, labora-
tory-reared mummies. Variation in pseudosclerotium germination
and apothecium development existed within populations (i.e., fun-
gal populations, which were probably heterogeneous, produced
individual stipes, apical invaginations, expanding tips, or mature
cups over a period of days). Circumstantial evidence supporting
genetic differences between fungal populations includes the fact
that the host is a perennial, and the fungal populations used in this
study were collected from bushes that were 40 to 50 years old.
Furthermore, both populations were in relatively close proximity
and were likely derived from a common population. Thus, differ-
ences in phenology of apothecium development were probably se-
lected rather than inherent differences of populations with distinct
origins. Although the evidence presented supports the hypothesis
that differences between fungal populations are genetic and likely
the results of host selection, additional populations from early-
and late-maturing blueberry cultivars need to be evaluated.
Despite differences in apothecium morphology between the two
populations, the species description of M. vaccinii-corymbosi fits
well in both cases (3). Preliminary results with random amplified
polymorphic DNA-polymerase chain reaction did not reveal poly-
morphisms between the two populations, but M. vaccinii-corym-
bosi was distinguished from M. galussacia by numerous poly-
morphisms (J. S. Lehman and P. V. Oudemans, unpublished data).
Morphological differences in apothecium height and width be-
tween 9420-WT and 9421-WT were potentially the result of selec-
tion under different environments. However, further research needs
to be conducted to substantiate this conclusion.
Few studies have addressed the role of host phenology in dis-
ease incidence. In highbush blueberry, Ehlenfeldt et al. (11) found
shoot length to be positively correlated with incidence of primary
infection and showed that the most susceptible cultivars tested were
also the most elongated. In studies by M. K. Ehlenfeldt, A. W.
Stretch, and J. S. Lehman (unpublished data), the susceptibility of
cv. Duke increased steadily from the close-bud state until vegeta-
tive buds had elongated 25 mm. Beyond 25 mm of growth, sus-
ceptibility to primary infection decreased significantly (i.e., there
was an optimum window of susceptibility). This is consistent with
the findings of Woronin (25) who found that the period of sus-
TABLE 2. Morphological dimensions of apothecia of Monilinia vaccinii-corymbosi for populations 9420-WT and 9421-WT from early- and late-fruiting blue-
berry cvs. Weymouth and Jersey, respectively
Population Cup diameter Cup depth (inner) Cup depth (outer) Stalk width Stalk length Apothecium height
9420-WT y5.5 ± 0.4 az 2.6 ± 0.2 a 3.3 ± 0.1 a 1.8 ± 0.1 a 6.0 ± 0.4 a 19.3 ± 0.5 b
9421-WT 5.3 ± 0.2 a 2.7 ± 0.2 a 3.4 ± 0.2 a 1.5 ± 0.1 b 7.2 ± 0.4 b 10.6 ± 0.6 a
z Values are the means (in millimeters) of ~350 newly formed apothecia. Within each column, means with letters in common do not differ significantly at α =
0.05.
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ceptibility of blueberry shoots may be related to the length of time
required for the young tissue to become fully cuticularized. In low-
bush blueberry, Hildebrand and Braun (14) demonstrated that sus-
ceptibility of truss buds increased as bud development progressed.
These studies suggest that an optimum time exists, based on host
development, for the pathogen population to develop apothecia
and release spores.
The fact that fungal development of populations 9420-WT and
9421-WT was distributed normally and could be described by a
mean and variance suggests there is an optimum time for stages of
fungal development that have significant epidemiological impor-
tance, such as the production of apothecia and ascospores. De-
pending on the range in periods of susceptibility, each cultivar
could act as a selective force on the phenology of the pathogen
population. In our study, when vegetative buds of Weymouth had
expanded 40 mm, 99% of the pseudosclerotia produced in arti-
ficial inoculations with population 9420-WT had developed into
mature, sporulating apothecia, whereas less than 10% of the pseudo-
sclerotia for population 9421-WT had produced apothecia. In
contrast, when buds of Jersey had expanded 40 mm, the majority
of apothecia of population 9420-WT had been present for 2.5
weeks and were beginning to decline, whereas 85% of those for
population 9421-WT were present. This suggests that isolates of
M. vaccinii-corymbosi with a phenology that corresponds to that
of Weymouth would be more likely to infect than isolates that
develop later. Such isolates would have a reproductive advantage
and increase in frequency provided that variation in pathogen phe-
nology (e.g., timing and rate of apothecium development) is con-
trolled genetically.
In conclusion, our results suggest there is variation in the phe-
nological development within and between populations of M. vac-
cinii-corymbosi. A portion of the variation between populations is
under genetic control and may enable adaptation of fungal popula-
tions to the phenologies of different host cultivars. Despite the
potential for pathogen adaptation, disease avoidance may provide
a useful means of controlling M. vaccinii-corymbosi as long as
pathogen phenological development and its variation are described
for the region of host deployment. Hence, results of this study
could aid in developing resistant cultivars that avoid the spring
discharge of ascospores. In a broader context, this research em-
phasizes the role of pathogen phenology on the establishment of
disease and importance of variation in phenology in the adaptation
of fungal populations to host cultivars.
ACKNOWLEDGMENTS
This work was supported by a USDA Specific Cooperative Agreement
grant. We thank C. Ferrier for technical assistance.
LITERATURE CITED
 1. Abawi, G. S., and Grogan, R. G. 1979. Epidemiology of diseases caused
by Sclerotinia species. Phytopathology 69:899-904.
 2. Batra, L. R. 1983. Monilinia vaccinii-corymbosi (Sclerotiniaceae): Its bi-
ology on blueberry and comparison with related species. Mycologia 75:
131-152.
 3. Batra, L. R. 1991. World Species of Monilinia (Fungi): Their Ecology,
Biosystematics and Control. J. Cramer, Berlin.
 4. Brewster, V., Stretch, A. W., and Ehlenfeldt, M. K. 1995. A technique for
producing conidia of Monilinia vaccinii-corymbosi on artificial media.
(Abstr.) Phytopathology 85:1200.
 5. Bristow, P. R., 1979. Mummy berry disease: Mummy germination. Pages
163-169 in: Proc. 4th North Am. Blueberry Res. Workers Conf. Division
of Continuing Education, University of Arkansas, Fayetteville.
 6. Burdon, J. J. 1987. Diseases and Plant Population Biology. Cambridge
University Press, Cambridge.
 7. Campbell, C. L., and Madden, L. V. 1990. Introduction to Plant Disease
Epidemiology. John Wiley & Sons, New York.
 8. Caruso, F. L., and Ramsdell, D. C. 1995. Compendium of Blueberry and
Cranberry Diseases. The American Phytopathological Society, St. Paul,
MN.
 9. Cochran, W. G., and Cox, G. M. 1957. Experimental Designs. 2nd ed.
John Wiley & Sons, New York.
 10. Darrow, G. M., and Scott, D. H. 1966. Varieties and their characteristics.
Pages 94-110 in: Blueberry Culture. P. Eck and N. F. Childers, eds.
Rutgers University Press, New Brunswick, NJ.
 11. Ehlenfeldt, M. K., Stretch, A. W., and Brewster, V. 1996. Genetic and
morphological factors influence mummy berry blight resistance in high-
bush blueberry cultivars. HortScience 31:252-254.
 12. Hancock, J. F., and Draper, A. D. 1989. Blueberry culture in North Amer-
ica. HortScience 24:551-556.
 13. Hartl, D. L., and Clark, A. G. 1989. Population Genetics. 2nd ed. Sin-
auer Associates, Inc., Sunderland, MA.
 14. Hildebrand, P. D., and Braun, P. G. 1991. Factors affecting infection of
lowbush blueberry by ascospores of Monilinia vaccinii-corymbosi. Can.
J. Plant Pathol. 13:232-240.
 15. Lehman, J. S., and Oudemans, P. V. 1995. Differences in rates of apo-
thecium development between populations of Monilinia vaccinii-corym-
bosi. (Abstr.) Phytopathology 85:1133.
 16. Milholland, R. D. 1974. Factors affecting apothecium development of
Monilinia vaccinii-corymbosi from mummified highbush blueberry fruit.
Phytopathology 64:296-300.
 17. Milholland, R. D. 1977. Sclerotium germination and histopathology of
Monilinia vaccinii-corymbosi on highbush blueberry. Phytopathology 67:
848-854.
 18. Nelson, J. W., and Bittenbender, H. C. 1971. Mummy berry disease occur-
rence in a blueberry selection test planting. Plant Dis. Rep. 55:651-653.
 19. Nyquist, W. E. 1991. Estimation of heritability and prediction of se-
lection response in plant populations. Crit. Rev. Plant Sci. 10:235-322.
 20. Pepin, H. S., and Toms, H. N. W. 1969. Susceptibility of highbush blue-
berry varieties to Monilinia vaccinii-corymbosi. Phytopathology 59:1876-
1878.
 21. Ramsdell, D. C., Nelson, J. W., and Myers, R. L. 1974. An epidemiological
study of mummy berry disease of highbush blueberry. Phytopathology
64:222-228.
 22. Ramsdell, D. C., Nelson, J. W., and Myers, R. L. 1975. Mummy berry
disease of highbush blueberry: Epidemiology and control. Phytopathol-
ogy 65:229-232.
 23. Stretch, A. W., Ehlenfeldt, M. K., and Brewster, V. 1995. Mummy berry
disease blight resistance in highbush blueberry cultivars. HortScience 30:
589-591.
 24. Varney, E. H., and Stretch, A. W. 1966. Diseases and their control. Pages
236-279 in: Blueberry Culture. P. Eck and N. F. Childers, eds. Rutgers
University Press, New Brunswick, NJ.
 25. Woronin, M. 1888. Über die sclerotienkrankheit der vaccinieen-beeren.
Mem. Acad. Imp. Sci. St. Petersbourg 36(6):1-49.
